Table 3 Headache-associated disability scores pre- and post- treatment with OnabotulinumtoxinA
From: OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients
ID | HIT-6 | MIDAS | HAD-A | HAD-D | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre | Post | Change in score | Pre | Post | Change in score | Pre | Post | Change in score | Pre | Post | Change in score | |
1 | 65 | 58 | 7 | 73 | 0 | 73 | 10 | 8 | 2 | 9 | 3 | 6 |
2 | 57 | 36 | 21 | 24 | 0 | 24 | 1 | 0 | 1 | 0 | 0 | 0 |
3 | 56 | 68 | −12 | 52 | 52 | 0 | 3 | 9 | −6 | 2 | 12 | −10 |
4 | 68 | 67 | 1 | 105 | 130 | −25 | 12 | 6 | 6 | 10 | 8 | 2 |
5 | 67 | 44 | 23 | 120 | 0 | 120 | 9 | 2 | 7 | 9 | 1 | 8 |
6 | 63 | 60 | 3 | 121 | 13 | 108 | 16 | 18 | −2 | 15 | 15 | 0 |
7 | 63 | 54 | 9 | 24 | 13 | 9 | 2 | 3 | −1 | 5 | 7 | −2 |
8 | 64 | 62 | 2 | 240 | 4 | 236 | 0 | 0 | 0 | 3 | 0 | 3 |
9 | 76 | 24 | 52 | 51 | 0 | 51 | 12 | 0 | 12 | 4 | 0 | 4 |
Mean | 64 | 53 | 12 | 90 | 24 | 66 | 7 | 5 | 2 | 6 | 5 | 1 |
Median (Range) | 64 (56–76) | 58 (24–68) | 7 (−12 to 52) | 73 (24–240) | 4 (0–130) | 51 (−25 to 236) | 9 (0–16) | 3 (0–18) | 1 (−6 to 12) | 5 (0–15) | 3 (0–15) | 2 (−10 to 8) |